Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Coppens

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 23, 2021
Delivery of AAV-based gene therapy through haemophilia centres-A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHCWolfgang Miesbach, Pratima Chowdary, Michiel Coppens, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 11, 2024
EAHAD haemophilia gene therapy clinical outcome database (EAHAD-GTD)Wolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 19, 2024
Administration of gene therapy for haemophilia - The hub and spoke model and its regional differences and challengesWolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
European Heart Journal|September 29, 2012
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapyMichiel Coppens, John W Eikelboom, Robert G Hart, et al.
Thrombosis and Haemostasis|July 3, 2015
Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trialsNoel C Chan, Alexander C Stehouwer, Jack Hirsh, et al.
Lupus|August 17, 2024
Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controlsValérie Lbi Jansen, Mark Davids, Dagmar Jm van Mourik, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 13, 2019
Professional functioning of young adults with congenital coagulation disorders in the NetherlandsPerrine F Limperg, Heleen Maurice-Stam, Lotte Haverman, et al.
European Journal of Heart Failure|February 25, 2017
Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysisHarriette G C Van Spall, Tahseen Rahman, Oliver Mytton, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES TrialVinai C Bhagirath, John W Eikelboom, Jack Hirsh, et al.
Heart (British Cardiac Society)|February 19, 2017
Effects of dabigatran according to age in atrial fibrillationMandy N Lauw, John W Eikelboom, Michiel Coppens, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 23, 2021
Delivery of AAV-based gene therapy through haemophilia centres-A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHCWolfgang Miesbach, Pratima Chowdary, Michiel Coppens, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 11, 2024
EAHAD haemophilia gene therapy clinical outcome database (EAHAD-GTD)Wolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 19, 2024
Administration of gene therapy for haemophilia - The hub and spoke model and its regional differences and challengesWolfgang Miesbach, Ana Boban, Pratima Chowdary, et al.
European Heart Journal|September 29, 2012
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapyMichiel Coppens, John W Eikelboom, Robert G Hart, et al.
Thrombosis and Haemostasis|July 3, 2015
Lack of consistency in the relationship between asymptomatic DVT detected by venography and symptomatic VTE in thromboprophylaxis trialsNoel C Chan, Alexander C Stehouwer, Jack Hirsh, et al.
Lupus|August 17, 2024
Gut microbiome composition and intestinal immunity in antiphospholipid syndrome patients versus healthy controlsValérie Lbi Jansen, Mark Davids, Dagmar Jm van Mourik, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 13, 2019
Professional functioning of young adults with congenital coagulation disorders in the NetherlandsPerrine F Limperg, Heleen Maurice-Stam, Lotte Haverman, et al.
European Journal of Heart Failure|February 25, 2017
Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysisHarriette G C Van Spall, Tahseen Rahman, Oliver Mytton, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES TrialVinai C Bhagirath, John W Eikelboom, Jack Hirsh, et al.
Heart (British Cardiac Society)|February 19, 2017
Effects of dabigatran according to age in atrial fibrillationMandy N Lauw, John W Eikelboom, Michiel Coppens, et al.
Pageof 15